Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice.

about

Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice.

Item

http://www.wikidata.org/entity/Q55040576

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Chemically triggered drug rele ...... t antitumour activity in mice.

@en

Chemically triggered drug rele ...... t antitumour activity in mice.

@nl

type

Item

label

Chemically triggered drug rele ...... t antitumour activity in mice.

@en

Chemically triggered drug rele ...... t antitumour activity in mice.

@nl

prefLabel

Chemically triggered drug rele ...... t antitumour activity in mice.

@en

Chemically triggered drug rele ...... t antitumour activity in mice.

@nl

P1476

Chemically triggered drug rele ...... t antitumour activity in mice.

@en

P2093

Alisher Khasanov

http://www.w3.org/2001/XMLSchema#string

Arthur H A M van Onzen

http://www.w3.org/2001/XMLSchema#string

Erik J Steenbergen

http://www.w3.org/2001/XMLSchema#string

Hans J Wessels

http://www.w3.org/2001/XMLSchema#string

Henk M Janssen

http://www.w3.org/2001/XMLSchema#string

Jeremy Wu

http://www.w3.org/2001/XMLSchema#string

Marc S Robillard

http://www.w3.org/2001/XMLSchema#string

Peter J Hudson

http://www.w3.org/2001/XMLSchema#string

Raffaella Rossin

http://www.w3.org/2001/XMLSchema#string

Ron M Versteegen

http://www.w3.org/2001/XMLSchema#string

P2860

Bioorthogonal Chemical Activation of Kinases in Living Systems

Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers.

Development of anti-MUC1 di-scFvs for molecular targeting of epithelial cancers, such as breast and prostate cancers.

Site-specific conjugation of monodispersed DOTA-PEGn to a thiolated diabody reveals the effect of increasing peg size on kidney clearance and tumor uptake with improved 64-copper PET imaging.

Diels-Alder reaction-triggered bioorthogonal protein decaging in living cells.

Tumour vascular targeting.

Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study

Anti-cancer therapies targeting the tumor stroma.

In Vivo Bioorthogonal Chemistry Enables Local Hydrogel and Systemic Pro-Drug To Treat Soft Tissue Sarcoma

Use of antibodies and immunoconjugates for the therapy of more accessible cancers.

P2888

s41467-018-03880-y

P304

1484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41467-018-03880-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103353438

http://www.w3.org/2001/XMLSchema#string

P698

29728559

http://www.w3.org/2001/XMLSchema#string

P932

5935733

http://www.w3.org/2001/XMLSchema#string